TSX:ACBPharmaceuticals
Why Aurora Cannabis (TSX:ACB) Investors Are Watching Trump’s Endorsement of CBD for Signs of Change
In recent days, President Donald Trump publicly promoted cannabidiol (CBD) as a prescription drug alternative and backed its potential to transform senior healthcare, sparking optimism about possible federal regulatory changes in the U.S. that could impact cannabis businesses.
Aurora Cannabis, which generates most of its revenue from medical cannabis, is especially exposed to benefits from regulatory shifts such as marijuana rescheduling that may ease financial and operational constraints...